CTOs on the Move

BenchSci

www.benchsci.com

 
For biomedical researchers who are starting experiments, BenchSci is a reagent intelligence platform that transforms published data into experiment-specific recommendations to reduce time, money and uncertainty in planning materials and methods.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.benchsci.com
  • 559 College Street Suite 201
    Toronto, ON CAN M6G 1A9
  • Phone: N/A

Executives

Name Title Contact Details

Funding

BenchSci raised $22M on 02/04/2020

Similar Companies

Waves

For 25+ years, Waves has been the world`s leading developer of professional audio plugins for music production, mixing, mastering, live sound, and post-production. In 2011, Waves received a Technical GRAMMY® Award to honor its innovative software, which is used to create hit recordings, major motion pictures, and top-selling video games. Waves also offers licensable algorithms for consumer electronics to dramatically enhance audio performance in products by Dell, Google, Fitbit, Asus, and more.

Propylon

As the world leader in legislative management solutions, Propylon offers the only end-to-end product suite that supports all aspects of the legislative process from idea to law. We also collaborate with leading publishers to deliver intelligent research products that grow your revenue. Driving transformation in the legal world, our innovative software solutions enable our clients to draft, manage, and understand legal content.

Ripple Effects

Ripple Effects is a San Francisco, CA-based company in the Software and Internet sector.

Zelis

Zelis Healthcare is a healthcare information technology company and market-leading provider of integrated healthcare cost management and payments solutions including network analytics and design, network access and cost management, claims cost management and electronic payments to payers, healthcare providers and consumers in the medical, dental and workers` compensation markets nationwide. Zelis Healthcare is backed by Parthenon Capital Partners.